Abstract
Seventeen adult Beagle dogs received intravenous digoxin, over periods up to 30 days, at doses intended to induce minimal toxicity. The clinical signs of toxicity and ECG changes were as expected but, in contrast to other reports, the clinical chemistry changes (potassium, sodium, chloride, urea, creatinine) were not reliable indicators of morphological changes in the kidney. Similarly, the CPK or LDH rises did not correlate well with cardiac toxicity. All dogs but one showed rises in plasma alanine aminotransferase.
Only the few dogs which died early in the study showed microscopic evidence of cardiac changes, although sub-endocardial haemorrhage was observed in others. Dogs which did not suffer too great an initial insult, such as occurs with the traditional loading dose regimen, appeared to withstand repeated treatment with a clinically toxic dose, and sustain no microscopically detectable cardiotoxicity. Focal renal tubular necrosis was found in 10 out of 14 dogs whose kidneys were examined, and five of these showed no cardiac changes. The converse, cardiac without renal changes, was not found.
Similar content being viewed by others
References
Brander GC, Pugh DH (1977) Veterinary applied pharmacology and therapeutics, Ch. 8. Baillière Tindall, London
Fillmore GE, Detweiler DK (1973) Maintenance of subacute digoxin toxicosis in normal beagles. Toxicol Appl Pharmacol 25: 418–429
Heptinstall RH (1974) Pathology of the kidney, vol. 2, 2nd edition. Little Brown and Co
Hu CH, Lieu VT, Li RC (1936) Anatomical changes in the hearts of dogs and frogs poisoned by glucosides of the digitalis group. Chinese Med J Suppl 1: 31–42
Kaneko JJ, Cornelius CE (eds) (1971) Clinical biochemistry of domestic animals vol II. Academic Press, New York London
Klein MS, Shell WE, Sobel BE (1973) Serum creatine phosphokinase (CPK) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Cardiovasc Res 7: 412–418
LaDue JS (1942) Myocardial necrosis and fibrosis resulting from the administration of massive doses of a cardiac glycoside. J Pharmacol Exp Ther 76: 1–10
Osborne BE, Dent NJ (1973) Electrocardiography and blood chemistry in the detection of myocardial lesions in dogs. Fd Cosmet Toxicol 11: 265–276
Overbeck HW (1981) Elevated arterial pressure, vascular wall “Waterlogging”, and impaired cardiac growth in rats chronically receiving digoxin. Proc Soc Exp Biol Med 167: 506–513
Schmid PG, Guo GB, Abboud FM (1980) Effects of digoxin on ADH release in dogs. Clin Res 28:473A
Steiness E, Bille-Brahe NE, Hansen JF, Lomholt N, Ring-Larsen H (1978) Reduced myocardial blood flow in acute and chronic digitalization. Acta Pharmacol Toxicol 43: 29–35
Teske RH, Bishop SP, Righter HF, Detweiler DK (1976) Subacute digoxin toxicosis in the beagle dog. Toxicol Appl Pharmacol 35: 283–301
Vatner SF, Higgins CB, Franklin D, Braunwald E (1971) Effects of a digitalis glycoside on coronary and systemic dynamics in conscious dogs. Circ Res 28: 470–479
Waters LL, deSuto-Nagy GI (1950) Circulatory factors in the pathogenesis of experimental arteriolar necrosis. Yale J Biol Med 22: 753–766
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bourdois, P.S., Dancla, JL., Faccini, J.M. et al. The sub-acute toxicology of digoxin in dogs; clinical chemistry and histopathology of heart and kidneys. Arch Toxicol 51, 273–283 (1982). https://doi.org/10.1007/BF00317006
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00317006